109 related articles for article (PubMed ID: 22130459)
21. Evaluation of intravenous parecoxib for the relief of acute post-surgical pain.
Jain KK
Expert Opin Investig Drugs; 2000 Nov; 9(11):2717-23. PubMed ID: 11060833
[TBL] [Abstract][Full Text] [Related]
22. Pharmacokinetics and bioavailability of nimesulide in goats.
Rao GS; Malik JK; Siddaraju VB; Shankaramurthy NC
J Vet Pharmacol Ther; 2007 Apr; 30(2):157-62. PubMed ID: 17348902
[TBL] [Abstract][Full Text] [Related]
23. An effective dose of valdecoxib in experimental mouse models of pain.
Guo CX; Irwin MG; Cheung KM; Chan D
Methods Find Exp Clin Pharmacol; 2007; 29(6):383-8. PubMed ID: 17922065
[TBL] [Abstract][Full Text] [Related]
24. Pharmacokinetic profiles of the novel COX-2 selective inhibitor cimicoxib in dogs.
Kim TW; Lebkowska-Wieruszewska B; Owen H; Yun HI; Kowalski CJ; Giorgi M
Vet J; 2014 Apr; 200(1):77-81. PubMed ID: 24461644
[TBL] [Abstract][Full Text] [Related]
25. Pharmacokinetics of intravenous and intramuscular tramadol in llamas.
Cox S; Martin-Jimenez T; van Amstel S; Doherty T
J Vet Pharmacol Ther; 2011 Jun; 34(3):259-64. PubMed ID: 21492191
[TBL] [Abstract][Full Text] [Related]
26. Simultaneous assessment of drug interactions with low- and high-extraction opioids: application to parecoxib effects on the pharmacokinetics and pharmacodynamics of fentanyl and alfentanil.
Ibrahim AE; Feldman J; Karim A; Kharasch ED
Anesthesiology; 2003 Apr; 98(4):853-61. PubMed ID: 12657846
[TBL] [Abstract][Full Text] [Related]
27. Safety and efficacy of the cyclooxygenase-2 inhibitors parecoxib and valdecoxib after noncardiac surgery.
Nussmeier NA; Whelton AA; Brown MT; Joshi GP; Langford RM; Singla NK; Boye ME; Verburg KM
Anesthesiology; 2006 Mar; 104(3):518-26. PubMed ID: 16508400
[TBL] [Abstract][Full Text] [Related]
28. The influence of parecoxib, a parenteral cyclooxygenase-2 specific inhibitor, on the pharmacokinetics and clinical effects of midazolam.
Ibrahim A; Karim A; Feldman J; Kharasch E
Anesth Analg; 2002 Sep; 95(3):667-73, table of contents. PubMed ID: 12198057
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics and bioavailability of imidocarb dipropionate in swine.
Su D; Li XB; Wang ZJ; Wang L; Wu WX; Xu JQ
J Vet Pharmacol Ther; 2007 Aug; 30(4):366-70. PubMed ID: 17610411
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and analgesic effectiveness of intravenous parecoxib for tonsillectomy ± adenoidectomy.
Tan L; Taylor E; Hannam JA; Salkeld L; Salman S; Anderson BJ
Paediatr Anaesth; 2016 Dec; 26(12):1126-1135. PubMed ID: 27779354
[TBL] [Abstract][Full Text] [Related]
31. Pharmacokinetics of marbofloxacin after intravenous and intramuscular administration to ostriches.
de Lucas JJ; Rodríguez C; Waxman S; González F; Uriarte I; San Andrés MI
Vet J; 2005 Nov; 170(3):364-8. PubMed ID: 16266851
[TBL] [Abstract][Full Text] [Related]
32. Valdecoxib (Pharmacia).
Gotta AW
Curr Opin Investig Drugs; 2002 Feb; 3(2):240-5. PubMed ID: 12020053
[TBL] [Abstract][Full Text] [Related]
33. Prostaglandin I2 release following mesenteric traction during abdominal surgery is mediated by cyclooxygenase-1.
Bucher M; Kees FK; Messmann B; Lunz D; Rath S; Zelenka M; Schlitt HJ; Hobbhahn J
Eur J Pharmacol; 2006 May; 536(3):296-300. PubMed ID: 16581062
[TBL] [Abstract][Full Text] [Related]
34. Multimodal pain management following minimally invasive total knee arthroplasty: an experience in 3-dose parecoxib.
Tanavalee A; Thiengwittayaporn S
J Med Assoc Thai; 2009 Dec; 92 Suppl 6():S11-8. PubMed ID: 20120661
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of moxifloxacin in rabbits after intravenous, subcutaneous and a long-acting poloxamer 407 gel formulation administration.
Cárceles CM; Serrano JM; Marín P; Escudero E; Fernández-Varón E
J Vet Med A Physiol Pathol Clin Med; 2006 Aug; 53(6):300-4. PubMed ID: 16901274
[TBL] [Abstract][Full Text] [Related]
36. A liquid chromatography-mass spectrometry method for the quantification of both etoricoxib and valdecoxib in human plasma.
Werner U; Werner D; Hinz B; Lambrecht C; Brune K
Biomed Chromatogr; 2005 Mar; 19(2):113-8. PubMed ID: 15473012
[TBL] [Abstract][Full Text] [Related]
37. Pharmacokinetics of the novel atypical opioid tapentadol following oral and intravenous administration in dogs.
Giorgi M; Meizler A; Mills PC
Vet J; 2012 Dec; 194(3):309-13. PubMed ID: 22771148
[TBL] [Abstract][Full Text] [Related]
38. Pharmacokinetics of nalbuphine hydrochloride after intravenous and intramuscular administration to Hispaniolan Amazon parrots (Amazona ventralis).
Keller DL; Sanchez-Migallon Guzman D; Klauer JM; KuKanich B; Barker SA; Rodríguez-Ramos Fernández J; Paul-Murphy JR
Am J Vet Res; 2011 Jun; 72(6):741-5. PubMed ID: 21627518
[TBL] [Abstract][Full Text] [Related]
39. Absorption of diazepam after its rectal administration in dogs.
Papich MG; Alcorn J
Am J Vet Res; 1995 Dec; 56(12):1629-36. PubMed ID: 8599525
[TBL] [Abstract][Full Text] [Related]
40. Differential inhibition of fracture healing by non-selective and cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs.
Gerstenfeld LC; Thiede M; Seibert K; Mielke C; Phippard D; Svagr B; Cullinane D; Einhorn TA
J Orthop Res; 2003 Jul; 21(4):670-5. PubMed ID: 12798067
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
